Skip to main content
. 2017 Jun 21;91(12):3857–3872. doi: 10.1007/s00204-017-2012-z

Table 3.

Glucuronides produced by incubation of different DON metabolites with rat or human liver microsomes

Substrate Type of microsome Glucuronides
DON RLM DON-3-GlcAc (comp 6, 100%) ≫ DON-8,15-hemiketal-8-GlcAc (comp 5, 5.2%) > DON-15-GlcAc (comp 7, 2.0%) > unknown DON-GlcAc (comp 2, 0.3%) > iso-DON-3-GlcAc (comp 9, 0.2%) ~iso-DON-8-GlcAc (comp 1, 0.1%)
DON HLM DON-15-GlcAc (comp 7, 100%) > DON-3-GlcAc (comp 6, 23%)
DOM RLM DOM-3-GlcAc (comp 12, 100%) ≫ DOM-15-GlcAc (comp 13, 2.6%) > unknown DOM-GlcAc b (comp 10, 0.8%) > unknown DOM-GlcAc a (comp 4, 0.3%) > iso-DOM-3-GlcAc (comp 14, <0.2%) ~iso-DOM-8-GlcAc (comp 3, <0.2%)
DOM HLM DOM-15-GlcAc (comp 13, 100%) ≫ DOM-3-GlcAc (comp 12, 7.7%)
Iso-DON RLM iso-DON-8-GlcAc (comp 1, 100%) > iso-DON-3-GlcAc (comp 9, 13%) > iso-DON-15-GlcAc (8.0%)
Iso-DON HLM iso-DON-15-GlcAc (100%) > iso-DON-3-GlcAc (comp 9, 29%)
Iso-DOM RLM iso-DOM-8-GlcAc (comp 3, 100%) > iso-DOM-3-GlcAc (comp 14, 54%) ~iso-DOM-15-GlcAc (54%)
Iso-DOM HLM iso-DOM-15-GlcAc (100%) ≫ iso-DOM-3-GlcAc (comp 12, 3.1%)

In brackets: relative intensities (values given relative to the major glucuronide in each assay) based on relative peak areas of the fragment m/z 113.0; comp: compound